ARCHETYPE General genomics results (openEHR-EHR-CLUSTER.general_genomics_results.v0)

ARCHETYPE IDopenEHR-EHR-CLUSTER.general_genomics_results.v0
ConceptGeneral genomics results
DescriptionGenomics sequencing result parameters that are calculated once per sequencing run.
UseUse to report general sequencing result parameter determined for the genome by a sequencing test. This archetype is meant to be used in the "Test result" SLOT of the Laboratory test result observation archetype.
MisuseNot to be used to report genetic variants, but only general parameters that are determined once per sequencing run.
PurposeTo record general sequencing result parameter of a performed sequencing test.
References
AuthorsAuthor name: Aurelie Tomczak
Organisation: Institute of Pathology, University Hospital Heidelberg
Email: au.tomczak@yahoo.com
Date originally authored: 2023-06-12
Other Details LanguageAuthor name: Aurelie Tomczak
Organisation: Institute of Pathology, University Hospital Heidelberg
Email: au.tomczak@yahoo.com
Date originally authored: 2023-06-12
Other Details (Language Independent)
  • Licence: This work is licensed under the Creative Commons Attribution-ShareAlike 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-sa/4.0/.
  • Custodian Organisation: HiGHmed
  • Original Namespace: org.highmed
  • Original Publisher: HiGHmed
  • Custodian Namespace: org.highmed
  • MD5-CAM-1.0.1: ED4B600784189F070211F7B91E093A58
  • Build Uid: e7bb8aa0-0957-4c37-8abf-b45a91537d43
  • Revision: 0.0.1-alpha
KeywordsTumor, cell, content, BRCAness, Microsatellite, instability, (MSI), Tumor, Mutational, Burden, (TMB), per, Mb, Sequencing, result, parameter, Whole, genome, sequencing, Targeted, sequencing, Homologous, recombination, deficiency, (HRD), score
Lifecyclein_development
UID2b744eb3-b3c8-43b3-9da3-e86649991dd3
Language useden
Citeable Identifier1246.145.2029
Revision Number0.0.1-alpha
items
Tumour cell content (pathologic/histologic)Tumour cell content (pathologic/histologic): Tumour cell content determinded by pathologic/histologic methods.
Choice of:
  •  Quantity
    Property: Qualified real
    Units: %
  •  Proportion
Tumour cell content (bioinformatic)Tumour cell content (bioinformatic): Tumour cell content determinded by bioinformatic methods.
Choice of:
  •  Proportion
  •  Quantity
    Property: Qualified real
    Units: %
Microsatellite instability (MSI)Microsatellite instability (MSI): Microsatellite instability (MSI).
min: >=0; max: <=2

MSI classificationMSI classification: Classification of the Microsatellite instability (MSI).
e.g. MSS, MSI low or MSI high.
Choice of:
  •  Coded Text
  •  Text
Tumor Mutational Burden (TMB) per MbTumor Mutational Burden (TMB) per Mb: Tumor Mutational Burden (TMB) per Megabase.
TMB classificationTMB classification: Classification of Tumor Mutational Burden (TMB) per Megabase.
e.g. low, intermediate or high.
Choice of:
  •  Text
  •  Coded Text
BRCAnessBRCAness: BRCAness is defined as a phenotypic copy of germline BRCA mutations.
Choice of:
  •  Count
    min: >=0; max: <=1

  •  Quantity
    Property: Qualified real
    Units: %
Homologous recombination deficiency (HRD) scoreHomologous recombination deficiency (HRD) score: The Homologous recombination deficiency (HRD) score is the sum of loss-of-heterozygosity (LOH), telomeric allelic imbalance (TAI), and large-scale state transitions (LST).
HRD classificationHRD classification: Classification of the Homologous recombination deficiency (HRD) score.
e.g. low, intermediate or high.
Further resultsFurther results: Cluster to include additional result parameters not already defined above.
NameName: Parameter name.
Choice of:
  •  Text
  •  Coded Text
  •  Identifier
ValueValue: Parameter value.
Value classificationValue classification: Classification of value.
e.g. low, intermediate or high.
Choice of:
  •  Coded Text
  •  Text
Qualitative interpretationQualitative interpretation: Qualitative parameter interpretation, if applicable.
Other contributors
Translators
  • German: Aurelie Tomczak, au.tomczak@yahoo.com, Institute of Pathology, University Hospital Heidelberg